Duncan Williams Reiterates Buy and PT of $80 on Varian Medical

by Emily Austin, Benzinga Staff Writer
July 27, 2011 9:15 AM | 12 seconds read |
Duncan Williams reiterated its Buy rating on Varian Medical VAR. At the same time, the rating agency left its price target on the company's stock unchanged at $80. On Tuesday, VAR closed the day at $68.57.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: ReiterationAnalyst RatingsDuncan WilliamsHealth CareHealth Care Equipment
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!